U.S. markets open in 3 hours 38 minutes
  • S&P Futures

    4,172.75
    +19.25 (+0.46%)
     
  • Dow Futures

    33,340.00
    +185.00 (+0.56%)
     
  • Nasdaq Futures

    14,114.50
    +79.50 (+0.57%)
     
  • Russell 2000 Futures

    2,244.50
    +13.90 (+0.62%)
     
  • Crude Oil

    71.91
    +0.27 (+0.38%)
     
  • Gold

    1,783.20
    +14.20 (+0.80%)
     
  • Silver

    26.07
    +0.10 (+0.37%)
     
  • EUR/USD

    1.1901
    +0.0035 (+0.30%)
     
  • 10-Yr Bond

    1.4500
    0.0000 (0.00%)
     
  • Vix

    19.87
    +2.12 (+11.94%)
     
  • GBP/USD

    1.3872
    +0.0063 (+0.45%)
     
  • USD/JPY

    110.1210
    -0.0290 (-0.03%)
     
  • BTC-USD

    33,254.76
    -2,008.93 (-5.70%)
     
  • CMC Crypto 200

    818.66
    -121.28 (-12.90%)
     
  • FTSE 100

    7,036.26
    +18.79 (+0.27%)
     
  • Nikkei 225

    28,010.93
    -953.15 (-3.29%)
     

In the Midst of This Pandemic, Arcturus Therapeutics Has Its Lightbulb Moment

·3 min read
  • Oops!
    Something went wrong.
    Please try again later.

In an RM article last week on Nano One Materials, I coined the phrase: the antidote to stagflation is innovation. This is stagflation. Many are using the threat of rising interest rates as an excuse to sell Nasdaq favorites and small-caps, with the general reason being that higher growth companies are more exposed to higher discount rates caused by higher interest rates.